Institutional investors purchased a net $1.3 million shares of MDCO during the quarter ended March 2014 and now own 107.43% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ROYCE & ASSOCIATES LLC Bought 456.6 Thousand shares of Medicines Co
CAPSTONE ASSET MANAGEMENT CO., I... Bought 4.2 Thousand shares of Medicines Co
CREDIT SUISSE AG Bought 2.5 Thousand shares of Medicines Co